MedTrace Logo

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

NCT01432002 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-12-21

No results posted yet for this study

Summary

The purpose of the study is:

* to assess the potential benefits of 18F-\[FDG\] PET/CT and PET/MRI for operable breast cancer in order to define the size and location of the primary tumor, as well as axillary, supraclavicular and internal mammary lymph nodes.
* to apply the imaging results to the simulation and the radiation treatment planning and partial breast for 3-D radiation treatment and partial breast irradiation with intensity modulated radiation treatment (IMRT).

Conditions

  • Breast Neoplasm

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Vincent Vinh-Hung, MD, PhD · Radiation Oncology, Geneva University Hospitals

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2013-05-31
Completion
2023-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01432002 on ClinicalTrials.gov